Schedule 13G ownership disclosure

PTC Therapeutics Inc

Security class unavailable · CUSIP: 69366J200

Event date: 2017-04-20

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
16.2000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001193805-17-000700
Form type
SC 13G
Filer
Complete Pharma Holdings II, LLC
CIK
CIK 1704768
Filed
Apr 27, 2017
Reporting period
Apr 20, 2017
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub